Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
Schrodinger (United States) · Foundation for Ichthyosis and Related Skin Types · +4 more institutions
Abstract
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the past few decades, free-energy calculations have benefited from improved force fields and sampling algorithms, as well as the advent of low-cost parallel computing. However, it has proven to be challenging to reliably achieve the level of accuracy that would be needed to guide lead optimization (∼5× in binding affinity) for a wide range of ligands and protein targets. Not surprisingly, widespread commercial application of free-energy simulations has been limited due to the lack of large-scale validation coupled with the technical challenges traditionally associated with running these types of calculations. Here, we…
Citation impact
- FWCI
- 114.47
- Percentile
- 100%
- References
- 50
Authors
29Topics & keywords
- Robustness (evolution)
- Chemistry
- Drug discovery
- False positive paradox
- Ligand efficiency
- Force field (fiction)
- Small molecule
- Ligand (biochemistry)
- Affordable and clean energy